Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome - Wikidata - wikimedia - TriplyDB

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

http://www.wikidata.org/entity/Q35574050

about

Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart Gene-dosage effects in Down syndrome and trisomic mouse models Cell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteins Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes Emerging pharmacotherapies for neurodevelopmental disorders Aneuploidy: cells losing their balance Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome Chromosome 21 and down syndrome: from genomics to pathophysiology Characterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTB Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome.PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+) /calmodulin-dependent kinase II-δ activation in mouse models of Down syndrome.Genetic dissection of the Down syndrome critical region.Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining.Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.Understanding the basis for Down syndrome phenotypes.Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy Profiling expression changes caused by a segmental aneuploid in maize.Meiotic behavior of aneuploid chromatin in mouse models of Down syndrome.Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening.Ohnologs in the human genome are dosage balanced and frequently associated with disease.Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model.Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21 The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.Gene expression analysis of the function of the male-specific lethal complex in Drosophila.Global DNA hypermethylation in down syndrome placenta Mechanisms of x chromosome dosage compensation.Structural variation-associated expression changes are paralleled by chromatin architecture modifications.Gene expression analysis of induced pluripotent stem cells from aneuploid chromosomal syndromes.Shotgun metabolomic profiles in maternal urine identify potential mass spectral markers of abnormal fetal biochemistry - dihydrouracil and progesterone in the metabolism of Down syndrome.Mouse models for Down syndrome-associated developmental cognitive disabilities Genetic analysis of Down syndrome-associated heart defects in mice.The use of mouse models for understanding the biology of down syndrome and aging The proteins of human chromosome 21.Gene expression variation in Down's syndrome mice allows prioritization of candidate genes Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes Down syndrome and genetics - a case of linked histories.

P2860

Q21184170-29288885-64C0-428E-81F4-266018C53943 Q21194863-60D1DD0C-455B-40E6-8855-B3B74A7ACEC5 Q21266589-F54A1968-3873-4C1F-8DD7-7B91975923D8 Q22337162-980808EA-6E49-4468-8628-7C807087EAFE Q24619170-AC2E9E55-D806-4C05-84AF-05526BD934FF Q24654413-F98D3394-DD37-43A2-BC79-1D534AEFC834 Q28117514-ECF9A223-6B15-4BD0-9C37-483321112907 Q28290257-2EEBA6B0-E9ED-44E3-8E44-388F61986A41 Q28478194-7EBCC8EA-DC52-4FCD-B3B8-C4BD6EB9750A Q30653697-B5ACB6B5-88B0-4691-92A2-95C9CCDF014D Q30668603-DEDF0771-6850-491B-999B-05687A2A453B Q30670043-380409F8-D4FB-4F7F-992C-D567BE44F33B Q30943859-75DA8DDF-2F0C-461E-9A21-FBA35E0012A7 Q31104439-817FDEFE-5FFF-494D-A30B-78F03FBDA9E6 Q33236637-74DC3D16-4A5B-4AC9-A844-B5D15B8E9302 Q33238943-D350E440-6116-4CE1-9867-2275C639CEF7 Q33293466-27A772AD-91B1-4356-B318-17BF763FEE9B Q33314156-65EB2017-D1C1-4B3C-A1DB-02698CCF36EE Q33767425-59C0AA77-E273-49DB-AC2F-E943EDB57B86 Q33886427-D0E3437D-8809-47F4-BCC6-4D15E8745BE2 Q33927314-A4C22450-DC63-4093-9E3B-914B12E78102 Q33927713-50FA1206-5563-4559-8557-CB4A7D3DA508 Q34229190-71125219-0DDD-4AB5-9B9D-1F17D7E50AD6 Q34302163-84FD9D6B-CB0F-4FD0-A312-B4ACCC8022F8 Q34325983-A8DF80C1-AFE4-434D-BCB1-98DCF7C42BEC Q34352054-381244C0-C286-41A7-ADC8-48932105C331 Q34572669-3C51FE4D-A97F-43D4-9812-D48EF6B2E093 Q34765333-7F5E72ED-BE2F-4C8B-8ACC-9E3C99E930AF Q35002469-F8F20006-4A71-4554-96DB-7243F6E82616 Q35050556-2654E882-5A85-48B8-8B80-5D18B8D45150 Q35101795-46F4AFB6-C4B7-4971-B95F-A88F152F202C Q35534981-BBEE755E-6776-4693-A980-BFA215E1ED42 Q35661597-8B9E61B8-9064-479F-BDB4-E126C1915163 Q35669274-22C50417-3C03-4073-B8EB-B14DC5A6604E Q35810481-908303DE-1E0C-4339-877A-80DA5A07E175 Q35821700-E7045CD2-3784-4380-94F1-142FDFB3BCD8 Q35906498-0D22D73B-35CF-4BAB-BAF3-CBDFD50AE7E4 Q35946259-29831C30-C1CF-41B6-8DA0-411D100D68A9 Q35946317-A7F6A9A7-6932-49D8-858D-216C77FC4B37 Q36004582-CB6E3C21-151D-4532-AE03-7725ED085569

P2860

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

http://www.wikidata.org/entity/Q35574050

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@ast

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@en

type

label

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@ast

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@en

prefLabel

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@ast

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@en

P1433

Q35574050-874817DD-78C7-4FDC-952D-88CFCB985836

P1476

Q35574050-71744918-5C03-40D7-AB72-6C88EACB7227

P2093

Q35574050-4AE8FF16-E51D-4913-9326-FBAA2231C8DC

Q35574050-7503031A-13AB-49CA-9273-DC5B10CC1BDD

Q35574050-A0CA1E66-CAA8-4EDA-B31E-8F315A525544

Q35574050-AA727770-311B-4303-9128-9ED7FDEE3131

P2860

Q35574050-07557A8F-362F-4E69-9D5C-163EFDCAAD74

Q35574050-0EF70D48-35D5-4AA3-9ADC-D74DA098E43A

Q35574050-108CCC25-C78E-48D8-B4F9-E68008200CC9

Q35574050-1B4F74DF-A42C-4FE8-BAEE-3380DA1BC7C7

Q35574050-1E756F3B-43E4-4A0B-8AA0-F4A189C96118

Q35574050-2A21D6AD-1875-4ABD-872B-61D9556347A2

Q35574050-39E298CA-1837-44EB-9ACE-C22FDCA00D50

Q35574050-3C5159D1-6459-42B1-BAE2-3497E27C8D0A

Q35574050-4083DB4F-9456-4B99-94DC-8E62876102CE

Q35574050-65F2D76F-F673-41DF-91CF-A046622660BE

P304

Q35574050-FA3AC7E4-3534-4880-A3AD-DD8D51BB7694

P31

Q35574050-0524AB86-5647-4AC9-85BE-3A8C42C29583

P356

Q35574050-FEB26B20-DE39-4539-88A0-0B9D435E92F5

P433

Q35574050-F4231579-7EDA-4549-AA73-7EFBBC6827D0

P478

Q35574050-AC009A91-2B26-4079-8BEB-6D63165332A2

P50

Q35574050-D76E9BE2-C206-436F-A1B5-E8A122410396

P577

Q35574050-9C93E5E1-E2EF-47E2-9975-E5BD5D3FDAB1

P5875

Q35574050-F6567F4E-4ED0-469B-A9F4-D381211678A0

P698

Q35574050-25DAECFC-45F2-40DF-BB12-939C054FFABB

P932

Q35574050-2721E092-1D77-4476-893E-6309EC647BB7

P356

P1433

Genome Research

P1476

Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome

@en

P2093

Charlotte Neergaard-Henrichsen

http://www.w3.org/2001/XMLSchema#string

Corinne Gehrig

http://www.w3.org/2001/XMLSchema#string

Robert Lyle

http://www.w3.org/2001/XMLSchema#string

Samuel Deutsch

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The DNA sequence of human chromosome 21

Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain

Nineteen additional unpredicted transcripts from human chromosome 21

From PREDs and open reading frames to cDNA isolation: revisiting the human chromosome 21 transcription map

Genetics of gene expression surveyed in maize, mouse and man

The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals

The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.

Too much of a good thing: mechanisms of gene action in Down syndrome.

P304

1268-1274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GR.2090904

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Stylianos Antonarakis

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8476498

http://www.w3.org/2001/XMLSchema#string

P698

15231743

http://www.w3.org/2001/XMLSchema#string

P932

442141

http://www.w3.org/2001/XMLSchema#string